ELIZABETH BRANT: Open Payments
NPI 1508598640 · LEON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 21 payments from 12 companies in 2025. Trend: 2023 $167 · 2024 $357 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Grifols USA, LLC | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| PFIZER INC. | 1 | $25 |
| ABBVIE INC. | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: AUSTEDO XR, JARDIANCE, Kerendia, Prolastin-C Liquid, FANAPT, PREVNAR 20, UBRELVY, TZIELD.
Industry payments across IA — which companies pay providers there.
